Ipratropium
Articles · Lactation Safety Information · Published , updated
108624006
Articles
13th December 2019
Ethanol content of inhalers – What is the significance?
Ethanol is included as an excipient in many commonly prescribed inhalers, including some licensed for use in children. Patients may have ethical, religious or cultural… Beclometasone Beclometasone + Formoterol Beclometasone + Formoterol + Glycopyrronium bromide Budesonide + Formoterol Ethanol Fluticasone + Formoterol Formoterol Ipratropium Q&A Respiratory disorders Salbutamol Salbutamol + Beclometasone
20th April 2017
Safety in Lactation: Drugs for obstructive airways disease
Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Bronchodilators Most bronchodilators are considered to… Aclidinium bromide Aminophylline Bambuterol Beclometasone Budesonide Ciclesonide Ephedrine Fluticasone Formoterol Glycopyrronium Indacaterol Ipratropium Mepolizumab Mometasone Montelukast Nedocromil Obstetrics and gynaecology Olodaterol Omalizumab Paediatric and neonatal medicine Respiratory disorders Roflumilast Safety in Lactation Salbutamol Salmeterol Sodium cromoglicate Terbutaline Theophylline Tiotropium Umeclidinium bromide Umeclidinium bromide + Vilanterol Zafirlukast
16th November 2015
Drug-induced hypersalivation – what treatment options are available?
This Medicines Q&A summarises published studies or case reports concerning the pharmacological treatment of drug-induced hypersalivation (drooling or sialorrhoea), particularly hypersalivation caused by clozapine. Amisulpride Atropine Benzatropine Biperiden Botulinum A toxin Bupropion Clonidine Clozapine Glycopyrronium Guanfacine Hyoscine butylbromide Hyoscine hydrobromide Ipratropium Lofexidine Metoclopramide Moclobemide Oxybutynin Pirenzepine Propantheline Q&A Quetiapine Sulpiride Trihexyphenidyl
21st October 2015
Hypersalivation – what are the treatment alternatives to glycopyrronium and hyoscine?
This Medicines Q&A outlines possible alternatives to hyoscine hydrobromide and glycopyrronium in the treatment of non drug-induced hypersalivation. Amitriptyline Atropine Benzatropine Botulinum A toxin Cisapride Glycopyrronium Hyoscine (base) Hyoscine hydrobromide Ipratropium Metoprolol Modafinil Piracetam Propranolol Q&A Ranitidine Rotigotine Trihexyphenidyl
25th February 2014
Which commonly used nebuliser solutions are compatible?
Mixing of nebuliser solutions should only be undertaken in the best interests of the patient and only by a person competent and willing to do… Budesonide Colistimethate Fluticasone Ipratropium Pharmaceutical Stability Q&A Respiratory disorders Salbutamol Salbutamol + Ipratropium Terbutaline Tobramycin
20th May 2012
Safety in Lactation: Topical nasal decongestants
Drugs used for nasal decongestion have limited systemic absorption in the mother, and pose negligible risk to a breastfed infant. There is no published evidence… Ephedrine Ipratropium XylometazolineLactation Safety Information
Inhalation
Inhalation
-
Antimuscarinic bronchodilator
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties
Used in infants >1 month
21st April 2017
Intranasal
Intranasal